Women with three or more uterine fibroids — non-cancerous growths — during pregnancy are more likely to have infants with reduced birthweight and may need additional surveillance.

With the aid of a $75 million, five-year grant renewal, the Electronic Medical Records and Genomics Network (eMERGE) will venture beyond its current focus on monogenic disease to scoring research participants’ relative risk for complex heritable diseases such as cardiovascular disease, chronic kidney disease and type 2 diabetes.

A new study identified multiple genetic locations associated with the size and number of uterine fibroids — common non-cancerous uterine tumors.

Digna R. Velez Edwards, PhD, has been named director of Women’s Health Research, succeeding longtime director and founder, Katherine Hartmann, MD, PhD, associate dean of Clinical and Translational Scientist Development and professor of Obstetrics and Gynecology.

A certain genetic variant, in combination with the use of anti-inflammatory drugs like aspirin and ibuprofen during early pregnancy, may protect women from miscarriage.

An international team of scientists, including six from Vanderbilt University, has identified the first unique genetic determinants of body mass index (BMI) in people of African ancestry.